{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:08:16Z","timestamp":1765667296326,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Key Technologies R&D Program of the National Ministry of Science","award":["2018ZX10713002","2018ZX10713001-003","2018ZX10711001","2017ZX10104001-002"],"award-info":[{"award-number":["2018ZX10713002","2018ZX10713001-003","2018ZX10711001","2017ZX10104001-002"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.03.049","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:53:22Z","timestamp":1586480002000},"page":"3832-3838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Classification of measles cases from 2014 to 2018: Implications for progress towards measles elimination in China"],"prefix":"10.1016","volume":"38","author":[{"given":"Aili","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiying","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.03.049_b0005","first-page":"S251","article-title":"Global measles elimination efforts: the significance of measles elimination in the United States","volume":"189","author":"Strebel","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.049_b0010","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199411243312101","article-title":"The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program","volume":"331","author":"Peltola","year":"1994","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.03.049_b0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/377693","article-title":"Measles elimination in the United States","volume":"189","author":"Orenstein","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.049_b0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2991\/jegh.k.191007.001","article-title":"Measles resurgence in Europe: migrants and travellers are not the main drivers","volume":"9","author":"Leong","year":"2019","journal-title":"J Epidemiol Global Health"},{"key":"10.1016\/j.vaccine.2020.03.049_b0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MOP.0000000000000845","article-title":"Resurgence of measles in the United States: how did we get here?","volume":"32","author":"Feemster","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.vaccine.2020.03.049_b0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2471\/BLT.13.130195","article-title":"Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data","volume":"92","author":"Ma","year":"2014","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.03.049_b0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/inthealth\/ihx017","article-title":"Global and national laboratory networks support high quality surveillance for measles and rubella","volume":"9","author":"Xu","year":"2017","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2020.03.049_b0040","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.15585\/mmwr.mm6848a2","article-title":"Progress toward measles elimination \u2013 China, January 2013-June 2019","volume":"68","author":"Ma","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.03.049_b0045","doi-asserted-by":"crossref","first-page":"e0218782","DOI":"10.1371\/journal.pone.0218782","article-title":"Molecular characterization of measles viruses in China: Circulation dynamics of the endemic H1 genotype from 2011 to 2017","volume":"14","author":"Wang","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.049_b0050","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.vaccine.2015.11.006","article-title":"A measles outbreak in a middle school with high vaccination coverage and evidence of prior immunity among cases, Beijing, PR China","volume":"34","author":"Ma","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.049_b0055","doi-asserted-by":"crossref","first-page":"e0208161","DOI":"10.1371\/journal.pone.0208161","article-title":"Importance of real-time RT-PCR to supplement the laboratory diagnosis in the measles elimination program in China","volume":"13","author":"Cui","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.049_b0060","first-page":"364","article-title":"National measles surveillance plan","volume":"20","author":"China","year":"2014","journal-title":"Chin J Vacc Immuniz"},{"key":"10.1016\/j.vaccine.2020.03.049_b0065","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/S2214-109X(18)30492-3","article-title":"Classification of global measles cases in 2013\u201317 as due to policy or vaccination failure: a retrospective review of global surveillance data","volume":"7","author":"Patel","year":"2019","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2020.03.049_b0070","first-page":"146","article-title":"Epidemiology of measles in China, 2015\u20132016","volume":"24","author":"Su","year":"2018","journal-title":"Chin J Vacc Immuniz"},{"key":"10.1016\/j.vaccine.2020.03.049_b0075","first-page":"205","article-title":"Measles vaccines: WHO position paper \u2013 April 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Releve epidemiologique hebdomadaire"},{"key":"10.1016\/j.vaccine.2020.03.049_b0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virusres.2011.09.023","article-title":"Biological feasibility of measles eradication","volume":"162","author":"Bellini","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.03.049_b0085","first-page":"119","article-title":"Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic","volume":"11","author":"Pannuti","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2020.03.049_b0090","series-title":"Plotkin\u2019s vaccines","first-page":"579","article-title":"Measles vaccines","author":"Strebel","year":"2018"},{"key":"10.1016\/j.vaccine.2020.03.049_b0095","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1001\/jama.1990.03440180073035","article-title":"Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population","volume":"263","author":"Edmonson","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.03.049_b0100","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1128\/jcm.30.7.1778-1782.1992","article-title":"Secondary immune response in a vaccinated population during a large measles epidemic","volume":"30","author":"Ozanne","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.03.049_b0105","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.vaccine.2008.02.028","article-title":"Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000\u20132005","volume":"26","author":"Atrasheuskaya","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.049_b0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2471\/BLT.07.045484","article-title":"Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003","volume":"87","author":"Hyde","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.03.049_b0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.33321\/cdi.2009.33.3","article-title":"Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March-May 2006","volume":"33","author":"Sheppeard","year":"2009","journal-title":"Commun Dis Intell Quart Rep"},{"key":"10.1016\/j.vaccine.2020.03.049_b0120","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/cid\/ciy286","article-title":"Clinical characteristics of measles in previously vaccinated and unvaccinated patients in California","volume":"67","author":"Cherry","year":"2018","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.03.049_b0125","first-page":"S4","article-title":"The clinical significance of measles: a review","volume":"189","author":"Perry","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.049_b0130","article-title":"Ongoing outbreak with well over 4000 measles cases in Italy from January to end August 2017 \u2013 what is making elimination so difficult?","volume":"22","author":"Filia","year":"2017","journal-title":"Euro surveillance: bulletin Europeen sur les maladies transmissibles = Eur Commun Dis Bull"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.03.049_b0135","doi-asserted-by":"crossref","first-page":"S559","DOI":"10.1093\/infdis\/jir098","article-title":"Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission","volume":"204","author":"Rota","year":"2011","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:54Z","timestamp":1759401774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20304382"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classification of measles cases from 2014 to 2018: Implications for progress towards measles elimination in China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}